Feedback
Settings

Settings

Goto Application

1. CN113166081 - COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

PermaLink
Office
China
Application Number 201980078239.1
Application Date 11.11.2019
Publication Number 113166081
Publication Date 23.07.2021
Publication Kind A
IPC
C07D 275/06
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
275Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings
04condensed with carbocyclic rings or ring systems
06with hetero atoms directly attached to the ring sulfur atom
C07D 417/12
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
417Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/196
02containing two hetero rings
12linked by a chain containing hetero atoms as chain links
A61K 31/4245
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
41having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
4245Oxadiazoles
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
CPC
C07D 275/06
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
275Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
04condensed with carbocyclic rings or ring systems
06with hetero atoms directly attached to the ring sulfur atom
C07D 417/12
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
417Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
02containing two hetero rings
12linked by a chain containing hetero atoms as chain links
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
Applicants NOVARTIS AG
诺华股份有限公司
Inventors KATZ JOHANNES
J·卡茨
ROUSH WILLIAM
W·鲁斯
SEIDEL HANS MARTIN
H·M·塞德尔
SHEN DONGMING
沈东明
VENKATRAMAN SRIDHAR
S·文卡特拉曼
Agents 北京市中咨律师事务所 11247
北京市中咨律师事务所 11247
Priority Data 62/760,244 13.11.2018 US
62/760,248 13.11.2018 US
62/760,279 13.11.2018 US
62/795,373 22.01.2019 US
62/796,356 24.01.2019 US
62/796,361 24.01.2019 US
Title
(EN) COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY
(ZH) 用于治疗与NLRP活性相关的病症的化合物和组合物
front page image
Abstract
(EN) In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein.
(ZH) 在一个方面，本文的特征在于：具有式AA的化合物或其药学上可接受的盐，或其药学上可接受的盐，其中式A中示出的变量可以如本文中任何地方所定义。
Related patent documents
WO/2020/102100
EP3880666
JP2022506898
US17292887This application is not viewable in PATENTSCOPE because the national phase entry has not been published yet or the national entry is issued from a country that does not share data with WIPO or there is a formatting issue or an unavailability of the application.
# -